A runner tries to navigate a flooded section of sidewalk underneath the Longfellow Bridge in Cambridge, Mass. Jessica Rinaldi/The Boston Globe
statnews.com - by Kate Sheridan - February 15, 2019
. . . the potential risks of climate change — and the attendant increase in natural disasters — stand to outstrip any … incremental gains, as the companies described in recent risk assessment reports to the British nonprofit CDP.
Hurricanes and superstorms, power outages and flooding all threaten manufacturing facilities and research sites, particularly when animals are involved. Droughts, too, threaten critical water supplies. Forest fires, even if remote from a given plant or research facility, bring smoke and air pollution that can similarly disrupt the day-to-day work for drug makers and their supply chain . . .
. . . STAT surveyed the risk assessment plans for more than a dozen major pharmaceutical companies and spoke with officials at labs that survived extreme weather events and others who are planning to avoid their repercussions. All emphasized that the risks are already real — and underscored how hard the industry is working to prepare to meet the challenge.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/3WI3IIT3CNOZDBZ6NJGZ5CLNLU.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/MUCU7WJPZBMQRJTTH3BLWNO2Y4.jpg)
Recent Comments